CDTX vs FTNT · rev $1.3M vs P/E 56, rev $6.80B
Cidara Therapeutics Inc (CDTX) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
CDTX currently screens at market cap $6.96B. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the CDTX and FTNT stock pages for the full models.
Not investment advice.